GSK considers splitting up
GlaxoSmithKline is reportedly considering whether to split its business into a consumer health spin-off and standalone pharmaceutical and vaccines group.
According to a report in the Financial Times, which cited people familiar with the situation, chairman Philip Hampton has had discussions with major investors over breaking up the business.
“I have had these conversations [with Sir Philip]. The logic of [splitting] the business is pretty clear . . . The financial dynamics of consumer and pharma are pretty different,” one top-10 shareholder told the paper.
Another reportedly told the FT: “It has been a question on the table for a long time. We have been asking ‘what are you? Are you pharma? Are you consumer goods’? Emma came in with a fresh pair of eyes - there is potential for thinking that [a spin-off] would make sense . . . We have spoken to the board about it.”
Read more:http://www.pharmatimes.com/news/gsk_considers_splitting_up_1245326
According to a report in the Financial Times, which cited people familiar with the situation, chairman Philip Hampton has had discussions with major investors over breaking up the business.
“I have had these conversations [with Sir Philip]. The logic of [splitting] the business is pretty clear . . . The financial dynamics of consumer and pharma are pretty different,” one top-10 shareholder told the paper.
Another reportedly told the FT: “It has been a question on the table for a long time. We have been asking ‘what are you? Are you pharma? Are you consumer goods’? Emma came in with a fresh pair of eyes - there is potential for thinking that [a spin-off] would make sense . . . We have spoken to the board about it.”
Read more:http://www.pharmatimes.com/news/gsk_considers_splitting_up_1245326